National Institutes of Health: Psoriasis trials

The registry lists 24 Psoriasis studies with National Institutes of Health as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 3Phase 2 8No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Metabolic Profiling of Immune Responses in Immune-mediated DiseasesRecruitingNCT04864886
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
• Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in PsoriasisCompletedNCT04271735Not applicableResults posted
• Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis VulgarisCompletedNCT01999868Phase 2Results posted
• Anakinra for Inflammatory Pustular Skin DiseasesCompletedNCT01794117Phase 2Results posted
• Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3CompletedNCT00789880Phase 2Results posted
• Effect of Chronic Inflammation on Myocardial Perfusion and FunctionTerminatedNCT04870827
• Anti-Inflammatory Effects of Time-Restricted FeedingCompletedNCT04728165
• T and B Cell Responses in Autoimmune DiseasesTerminatedNCT01947036
• The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)CompletedNCT01778569
• Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisCompletedNCT00407979
• Genetic Analysis of Psoriasis and Psoriatic ArthritisCompletedNCT00341809
• Research in Skin InflammationCompletedNCT00026741
• Treatment of Psoriasis With Parathyroid HormoneCompletedNCT00007306Phase 1/2
• Scalp Psoriasis Treatment With a Fiber Optic CombCompletedNCT00007293Phase 1/2
• Micellar Paclitaxel to Treat Severe PsoriasisCompletedNCT00006276Phase 2
• Study of Topical Calcitriol in Children With PsoriasisCompletedNCT00006275Not applicable
• Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual MolesCompletedNCT00005781
• The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive DiseasesCompletedNCT00005660
• Study of Topical Calcitriol or Oral Calcitriol in Patients With PsoriasisWithdrawnNCT00004468Not applicable
• Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe PsoriasisCompletedNCT00001797Phase 2
• A Controlled Trial of Intermittent Fludarabine for Psoriatic ArthritisCompletedNCT00001422Phase 2
• Study of Psoriatic ArthritisCompletedNCT00001420
• A Pilot Study of Topical Antiflammin-2 for PsoriasisCompletedNCT00001371